UBS Group’s Nuveen Churchill Direct Lending NCDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.68M Sell
682,133
-6,917
-1% -$92.8K ﹤0.01% 3512
2025
Q4
$9.19M Buy
689,050
+196,956
+40% +$2.8M ﹤0.01% 3375
2025
Q3
$6.79M Buy
492,094
+48,157
+11% +$770K ﹤0.01% 3713
2025
Q2
$7.19M Buy
443,937
+272,267
+159% +$4.31M ﹤0.01% 3478
2025
Q1
$2.91M Sell
171,670
-3,037
-2% -$52.2K ﹤0.01% 4345
2024
Q4
$2.93M Buy
174,707
+86,729
+99% +$1.49M ﹤0.01% 4349
2024
Q3
$1.53M Buy
87,978
+82,478
+1,500% +$1.44M ﹤0.01% 4254
2024
Q2
$95.7K Sell
5,500
-21,972
-80% -$387K ﹤0.01% 6188
2024
Q1
$496K Buy
+27,472
New +$477K ﹤0.01% 5211

Other funds holding NCDL

UBS Group's NCDL Position: Q1 2026 in Review

UBS Group reduced its Nuveen Churchill Direct Lending (NCDL) stake by 1% in Q1 2026, selling an estimated $92.8K and leaving 682,133 shares worth $8.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3512.

UBS Group first reported a position in NCDL in Q1 2024 and has held it in 9 quarters since. The position peaked at $9.19M in Q4 2025. 67 funds tracked by Wall St. Rank hold NCDL as of Q1 2026.

  • UBS Group held 682,133 shares of Nuveen Churchill Direct Lending worth $8.68M as of Q1 2026.
  • UBS Group sold 6,917 Nuveen Churchill Direct Lending shares in Q1 2026, an estimated $92.8K.
  • Nuveen Churchill Direct Lending made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3512 holding.
  • UBS Group first reported a position in Nuveen Churchill Direct Lending in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's Nuveen Churchill Direct Lending position peaked at $9.19M in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Nuveen Churchill Direct Lending as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.